Amarin Corp Plc (AMRN)

[ramfan60]

Rose, I think that even if we develop a new formulation, it has to be something different and not be called icosapent ethyl. If it is the same molecule, then nothing changes for generics. If our icosapent ethyl is better stronger and faster..... it will not make a difference. Sure it may be cheaper to manufacture and we can lower costs and it could require less pills for the same 4g's but it won't move the needle in the US. Something has to be significantly different to effect the generic dynamic currently in place.